Sofinnova Investments as of Sept. 30, 2022
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 55 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 27.1 | $466M | 2.1M | 224.93 | |
| Cincor Pharma | 11.6 | $200M | 6.1M | 32.82 | |
| Natera (NTRA) | 7.9 | $136M | 3.1M | 43.82 | |
| Merck & Co Call Option (MRK) | 4.4 | $76M | 884k | 86.12 | |
| Vera Therapeutics Cl A (VERA) | 3.9 | $68M | 3.2M | 21.31 | |
| Aerovate Therapeutics (AVTE) | 3.6 | $62M | 3.8M | 16.58 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 3.0 | $52M | 500k | 103.26 | |
| Sanofi SA Sponsored Adr (SNY) | 2.8 | $48M | 1.3M | 38.02 | |
| Invesco QQQ Trust Series 1 Unit Ser 1 Put Option (QQQ) | 2.3 | $40M | 150k | 267.26 | |
| AstraZeneca Sponsored Adr (AZN) | 2.2 | $39M | 702k | 54.84 | |
| Health Care Select Sector SPDR Sbi Healthcare Put Option (XLV) | 2.1 | $36M | 300k | 121.11 | |
| iShares Russell 2000 ETF Russell 2000 Etf Put Option (IWM) | 1.9 | $33M | 200k | 164.92 | |
| Y Mabs Therapeutics (YMAB) | 1.8 | $32M | 2.2M | 14.42 | |
| United Therapeutics Corporation (UTHR) | 1.8 | $31M | 148k | 209.38 | |
| Gilead Sciences (GILD) | 1.7 | $30M | 482k | 61.69 | |
| BioMarin Pharmaceutical (BMRN) | 1.5 | $25M | 295k | 84.77 | |
| Cti Biopharma | 1.2 | $21M | 3.6M | 5.82 | |
| Reata Pharmaceuticals Cl A | 1.2 | $21M | 818k | 25.13 | |
| Intuitive Surgical (ISRG) | 1.1 | $18M | 96k | 187.44 | |
| Irhythm Technologies (IRTC) | 1.0 | $18M | 140k | 125.28 | |
| Dex (DXCM) | 1.0 | $17M | 206k | 80.54 | |
| Sarepta Therapeutics (SRPT) | 0.9 | $16M | 141k | 110.54 | |
| Cytokinetics (CYTK) | 0.9 | $16M | 321k | 48.45 | |
| Iveric Bio | 0.9 | $15M | 821k | 17.94 | |
| Eli Lilly & Co. (LLY) | 0.9 | $15M | 46k | 323.34 | |
| Inhibrx (INBX) | 0.8 | $14M | 800k | 17.95 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.7 | $13M | 583k | 21.66 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $13M | 525k | 24.03 | |
| Edwards Lifesciences (EW) | 0.7 | $12M | 147k | 82.63 | |
| Akouos | 0.6 | $10M | 1.5M | 6.76 | |
| Arcus Biosciences Incorporated (RCUS) | 0.6 | $10M | 381k | 26.16 | |
| Inozyme Pharma (INZY) | 0.6 | $9.8M | 3.7M | 2.68 | |
| Ideaya Biosciences (IDYA) | 0.6 | $9.8M | 655k | 14.92 | |
| Travere Therapeutics (TVTX) | 0.6 | $9.7M | 395k | 24.64 | |
| Prometheus Biosciences | 0.5 | $8.2M | 140k | 59.01 | |
| Nextcure (NXTC) | 0.4 | $7.3M | 2.7M | 2.75 | |
| Adicet Bio (ACET) | 0.4 | $7.0M | 492k | 14.22 | |
| Fulcrum Therapeutics (FULC) | 0.4 | $6.5M | 797k | 8.09 | |
| Nucana Biomed Sponsored Adr (NCNA) | 0.3 | $5.9M | 5.6M | 1.04 | |
| Chinook Therapeutics | 0.3 | $5.7M | 288k | 19.66 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $5.7M | 214k | 26.43 | |
| Galera Therapeutics (GRTX) | 0.3 | $5.4M | 3.1M | 1.74 | |
| Immatics NV SHS (IMTX) | 0.3 | $5.3M | 533k | 10.00 | |
| Geron Corporation (GERN) | 0.3 | $5.3M | 2.3M | 2.34 | |
| Arcutis Biotherapeutics (ARQT) | 0.3 | $5.2M | 274k | 19.11 | |
| Agenus (AGEN) | 0.3 | $5.0M | 2.4M | 2.05 | |
| Insmed Com Par $.01 (INSM) | 0.3 | $4.8M | 221k | 21.54 | |
| Bolt Biotherapeutics (BOLT) | 0.2 | $4.1M | 2.8M | 1.48 | |
| Nucana Biomed Ordinary Shares | 0.1 | $2.5M | 2.4M | 1.04 | |
| ImmunoGen | 0.1 | $2.4M | 502k | 4.78 | |
| Ngm Biopharmaceuticals Call Option (NGM) | 0.1 | $2.0M | 150k | 13.08 | |
| Obseva Sa | 0.0 | $675k | 4.7M | 0.14 | |
| Synlogic | 0.0 | $546k | 575k | 0.95 | |
| Pds Biotechnology Ord (PDSB) | 0.0 | $424k | 143k | 2.97 | |
| Fusion Pharmaceuticals (FUSN) | 0.0 | $352k | 117k | 3.01 |
